Efficacy of second-line ICIs combined with TKIs among patients with metastatic renal cell carcinoma: a real-world study.
Zhang H, Chen J, Zhang X, Zhu X, Wang Z, Sun G, Liang J, Chen Y, Shen Y, Liu J, Li X, Wei Q, Liu Z, Zeng H, Shen P.
Zhang H, et al. Among authors: shen y, shen p.
Immunotherapy. 2022 Apr;14(5):309-320. doi: 10.2217/imt-2021-0108. Epub 2022 Feb 21.
Immunotherapy. 2022.
PMID: 35187953